MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Measuring salivary cortisol levels in persons with Parkinson’s disease (PD)

A. Hiller, B. Lobb, J. Proulx, J. Quinn (Portland, OR, USA)

Meeting: 2018 International Congress

Abstract Number: 1774

Keywords: Anxiety, Disease-modifying strategies, Neurobehavioral disorders

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Psychiatric Manifestations

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To better characterize the relationship between salivary cortisol and psychological stress in persons with Parkinson’s disease (PD).

Background: Psychological stress is known to exacerbate the symptoms of PD and in animal models is deleterious to the nervous system.(Marsden 1967, Hemmerle 2012) Increased stress may contribute to the development of PD and to faster disease progression. Salivary cortisol is an objective measure of stress and is known to accurately reflex serum cortisol, however it has not been well characterized in PD. Better characterization in PD could assist in future studies examining the interplay of emotional stress and stress reduction in PD.

Methods: Saliva will be collected at awakening, 30 minutes after, at noon, and bedtime for three days. We will enroll four groups of 20 persons each: 1) persons with PD and high levels of stress, 2) PD and low levels of stress, 3) controls with high stress, and 4) controls with low stress. Psychological scales will include: the Perceived Stress Scale, and the Hamilton Anxiety and Depression Rating Scales. We will examine the correlation between measures on psychological scales and salivary cortisol. We will compare the awakening response (change in cortisol between awakening and 30 minutes after) and diurnal variation between the 3 groups.

Results: We have IRB approval and have enrolled over 70% of our target numbers. A preliminary analysis was presented at the 2017 AD/PD meeting. At approximately 50% of target enrollment the most notable data was a significant correlation between the cortisol awakening response in person’s with PD and high stress (R2=0.32, p=0.03) that was not seen in persons with PD and low stress (R2=0.30, p=0.10). We project to finish enrollment by early summer and analyze the additional cortisol samples in a batch at that time.

Conclusions: To successfully study the relationship between psychological stress and PD markers of target engagement are necessary. Salivary cortisol first needs to be better characterized in PD prior to using it as such a marker.

References: Marsden, C. D., and Owen, D. A. 1967. Mechanisms underlying emotional variation in parkinsonian tremor. Neurology 17 (7) (Jul): 711-5. Hemmerle, A. M., Herman, J.P., and Seroogy, K. B. 2012. Stress, depression and parkinson’s disease. Experimental Neurology 233 (1) (Jan): 79-86.

To cite this abstract in AMA style:

A. Hiller, B. Lobb, J. Proulx, J. Quinn. Measuring salivary cortisol levels in persons with Parkinson’s disease (PD) [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/measuring-salivary-cortisol-levels-in-persons-with-parkinsons-disease-pd/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/measuring-salivary-cortisol-levels-in-persons-with-parkinsons-disease-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley